Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.




Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA)



Rox PharmacySponsored by RoxPharmacy.com - Online Pharmacy, an pharmacy online supplies more than 500 quality generic products, free prescription, worldwide shipping.
xanax

Online Canadian Pharmacy canada pharmacy
Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • LinkedIn
  • Live
  • StumbleUpon
  • Yahoo! Buzz
  • Slashdot
  • Technorati
  • MSN Reporter

Related posts:

  1. European Medicines Agency Recommends Withdrawal Of Dextropropoxyphene-Containing Medicines (Including Co-Proxamol)
  2. European Medicines Agency Implements Internal Reorganisation
  3. European Medicines Agency Recommends First Marketing Authorisation For Cell-Based Medicine That Repairs Femoral Condyle Cartilage Defects